Amgen
The Clinical Development Director leads early phase clinical development of compounds from first-in-human studies through proof-of-concept. This role involves collaborating with cross-functional teams to support the design and delivery of early phase clinical trials, including protocol and IND development, study start-up, data review, monitoring, and analysis. The position focuses on contributing to the clinical development strategy for therapeutic candidates in Inflammation, General Medicine, or Rare Disease.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
42% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Clinical Development Director, Early Development – Inflammation/Rare Disease
lifelancer
Vice President of Translational Medicine
Flagship Pioneering, Inc.
Senior Medical Director, Kidney Disease, Early Clinical Development CVRM
American Association of Physicists in Medicine
Vice President of Translational Medicine
Flagship Pioneering, Inc.
Clinical Research Physician
Eli Lilly and Company
Senior Clinical Lead, Early Clinical & Experimental Therapeutics
sanofi us